Skip to content
Markets News
Earnings1 min read

Cardinal Health Lifts FY2027 EPS Outlook After Strong Quarter

Makkler Newsroom
November 5, 2026 · Based on reporting by PR Newswire

The company reported 5% revenue growth and higher adjusted earnings, then raised its full-year non-GAAP EPS guidance to $12.80-$13.00.

Key takeaways

  • First-quarter revenue rose 5% to $67.5 billion.
  • Non-GAAP diluted EPS increased 28% to $3.26.
  • Cardinal Health raised its fiscal 2027 non-GAAP EPS outlook to $12.80-$13.00.
  • The company completed a $500 million share repurchase program in the quarter.

Cardinal Health raised its fiscal 2027 non-GAAP diluted EPS outlook to $12.80-$13.00 after reporting first-quarter revenue of $67.5 billion, up 5% year over year. Non-GAAP diluted EPS rose 28% to $3.26.

The company’s new forecast compares with its previous range of $12.40-$12.60. Cardinal Health said the updated outlook represents 17%-19% growth against its fiscal 2026 baseline excluding a tariff refund, and 14%-15% growth against reported fiscal 2026 results.

First-quarter GAAP operating earnings increased 13% to $753 million, while GAAP diluted EPS rose 27% to $2.38. The company said higher non-GAAP operating earnings, a lower share count and a lower effective tax rate contributed to adjusted EPS growth.

Pharmaceutical and Specialty Solutions revenue rose 6% to $62.6 billion, with segment profit up 17% to $783 million. Global Medical Products and Distribution revenue was $3.2 billion, roughly flat year over year, while segment profit fell 28% to $33 million.

Cardinal Health also completed a $500 million share repurchase program during the quarter. It raised its expected profit growth for Pharmaceutical and Specialty Solutions and its “Other” businesses, and lowered its expected non-GAAP effective tax rate to 18.5%-19.5%.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.